Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118853042 | 11885304 | 2 | F | 20160701 | 20160104 | 20160708 | PER | US-009507513-1512USA006606 | MERCK | 30.00 | YR | F | Y | 0.00000 | 20160708 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
118853042 | 11885304 | 1 | PS | ISENTRESS | RALTEGRAVIR POTASSIUM | 1 | Oral | TOTAL DAILY DOSE: 800 (UNIT NOT REPORTED) | 22145 | TABLET | |||||||||
118853042 | 11885304 | 2 | SS | cobicistat (+) elvitegravir (+) emtricitabine (+) tenofovir disoproxil | COBICISTATELVITEGRAVIREMTRICITABINETENOFOVIR | 1 | Oral | TOTAL DAILY DOSE: 1 (UNIT NOT REPORTED) | 0 | ||||||||||
118853042 | 11885304 | 3 | SS | DARUNAVIR | DARUNAVIR | 1 | Oral | TOTAL DAILY DOSE: 800 (UNIT NOT REPORTED) | 0 | ||||||||||
118853042 | 11885304 | 4 | SS | RITONAVIR. | RITONAVIR | 1 | Oral | TOTAL DAILY DOSE: 100 (UNIT NOT REPORTED) | 0 | ||||||||||
118853042 | 11885304 | 5 | SS | emtricitabine (+) tenofovir disoproxil fumarate | EMTRICITABINETENOFOVIR DISOPROXIL | 1 | Oral | TOTAL DAILY DOSE: 1 (UNIT NOT REPORTED) | 0 |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
118853042 | 11885304 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |